Contact this trialFirst, we need to learn more about you.
Psychedelic Substance
Psilocybin for PTSD
Recruiting1 awardPhase 2
Windsor, Nova Scotia
This trial is testing psilocybin, a substance from 'magic mushrooms,' on people with PTSD who don't respond to current treatments. Psilocybin helps the brain grow and reduces fear response, which may improve mood and reduce anxiety. Psilocybin has shown promise in treating anxiety and depression in patients with life-threatening cancer, with significant and sustained symptom reduction.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service